WHO Good Distribution Practices for Pharmaceutical Products
WHO good distribution practices for pharmaceutical products (Technical Report Series No. 957, Annex 5), the reference GDP standard widely adopted by regulators in emerging markets. Covers the quality system, storage and warehousing, transportation, and the controls needed to preserve product integrity across the supply chain.
What this does not cover
stated in the document's own scope- Covers distribution of finished pharmaceutical products, not their manufacture, which is governed by GMP.
- Addresses the general distribution chain; cold-chain-specific storage detail is elaborated in WHO good storage and cold-chain guidance.
- Is WHO guidance, not law; its force depends on adoption by each national regulatory authority.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
WHO Good Distribution Practices for pharmaceutical products is the reference GDP standard published as Annex 5 of WHO Technical Report Series (TRS) No. 957. It sets out the controls needed to preserve the quality and integrity of medicines as they move through the distribution chain from the manufacturer to the point of use. It covers the quality system a distributor must operate, personnel and premises, storage and warehousing conditions, stock rotation and temperature control, transportation and transit, documentation and traceability, handling of returns and recalls, and measures against counterfeit products. It is widely adopted by regulators in emerging markets as their baseline distribution standard.
Scope & applicability
Distribution of pharmaceutical products in jurisdictions that reference WHO norms. Frequently the operative GDP baseline where a national GDP guideline is not yet established.
Legal basis & how it acquires force
The WHO GDP text is a recommendation adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations and published in the Technical Report Series; it is guidance, not law. It becomes binding when a national regulatory authority adopts it into its own distribution rules or licensing requirements. Many countries — particularly those without a large domestic GDP framework of their own — take the WHO Annex directly as their national standard, which is the mechanism that gives TRS 957 Annex 5 its practical authority.
Document structure
| Part | Covers |
|---|---|
| Quality management | The quality system, responsibilities, and management of the distribution operation |
| Personnel and premises | Trained personnel and suitable, secure storage premises |
| Storage and stock control | Storage conditions, temperature control, segregation, and stock rotation (FEFO) |
| Transportation and transit | Maintaining conditions and security of products in transport and transit |
| Documentation and traceability | Records that allow a product to be traced through the chain |
| Returns, recalls, and counterfeits | Handling returned goods, executing recalls, and controls against falsified products |
Key requirements
- A quality system covering the full distribution operation
- Controlled, monitored storage and transportation conditions
- Documentation and traceability of received and dispatched products
- Handling of complaints, returns, recalls, and counterfeit products
Implementation tips
- Use TRS 957 Annex 5 as the baseline where no national GDP guideline exists, layering local requirements on top
Revision notes
Issued in WHO Technical Report Series No. 957 (2010); later WHO guidance (e.g. TRS 1025 storage and distribution) supplements it.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
The WHO GDP standard is the multilateral counterpart to the EU Guidelines on Good Distribution Practice (2013/C 343/01) and to national GDP frameworks; the three share the same objective of preserving product integrity across the supply chain. It complements WHO Good Storage Practices and the GMP standards that precede distribution, and it is the standard most often adopted by regulators that reference WHO texts rather than maintaining their own detailed GDP guideline.
WHO TRS 957, Annex 5: frequently asked questions
Quick answers to common questions about WHO TRS 957, Annex 5.
Where is the WHO GDP standard published?
It is Annex 5 of WHO Technical Report Series (TRS) No. 957, adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations. It is the reference GDP standard widely used by regulators in emerging markets.
Is WHO GDP legally binding?
Not on its own. It is a WHO recommendation. It becomes binding when a national regulatory authority adopts it into its distribution rules or licensing requirements — which many countries do directly.
How does WHO GDP relate to EU GDP?
They are counterparts with the same aim of preserving product integrity in the supply chain. WHO GDP (TRS 957 Annex 5) is the multilateral reference; the EU Guidelines on Good Distribution Practice are the corresponding EU framework.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.